Literature DB >> 13784057

Protective activity of fractions of tubercle bacilli against isologous tumours in mice.

D W WEISS, R S BONHAG, K B DEOME.   

Abstract

Entities:  

Keywords:  MYCOBACTERIUM TUBERCULOSIS/extracts; NEOPLASMS/experimental

Mesh:

Year:  1961        PMID: 13784057     DOI: 10.1038/190889a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  21 in total

1.  SURVIVAL OF SPLEEN CELLS TRANSPLANTED INTO SYNGENEIC AND ALLOGENEIC MICE DURING STIMULATION OF THE RETICULO-ENDOTHELIAL SYSTEM INDUCED BY MYCO. TUBERCULOSIS (BCG) INFECTION.

Authors:  G BIOZZI; C STIFFEL; D MOUTON; Y BOUTHILLIER; C DECREUSEFOND
Journal:  Br J Exp Pathol       Date:  1964-08

2.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

3.  Immunological relationships of some oncogenic DNA viruses. I. Transplantation immunity studies.

Authors:  C W Potter; J M Hoskins; J S Oxford
Journal:  Arch Gesamte Virusforsch       Date:  1969

4.  Effect of splenectomy on the growth of adenovirus 12 tumors in hamsters.

Authors:  P Erb; L Baselgia; M Gasser; A Honegger; H Loeffler
Journal:  Experientia       Date:  1974-08-15

5.  Use of vaccinia virus in the treatment of metastatic malignant melanoma.

Authors:  I Hunter-Craig; K A Newton; G Westbury; B W Lacey
Journal:  Br Med J       Date:  1970-05-30

6.  Studies on the mode of action of the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG).

Authors:  C B Steinkuller; L G Krigbaum; D W Weiss
Journal:  Immunology       Date:  1969-02       Impact factor: 7.397

7.  Immunity to malignant disease in man.

Authors:  G H Fairley
Journal:  Br Med J       Date:  1969-05-24

8.  Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.

Authors:  D L Morton; F R Eilber; W L Joseph; W C Wood; E Trahan; A S Ketcham
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969

9.  Oestrogen as a reticuloendothelial stimulant in patients with cancer.

Authors:  C J Magarey; M Baum
Journal:  Br Med J       Date:  1971-05-15

10.  Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.

Authors:  D Juy; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.